Loading organizations...
BioMed Ventures operates as a specialized venture capital firm concentrating its investments within the expansive life science sector. It strategically deploys capital into early-stage biotechnology, medical device, and related life science companies, providing essential financial backing. This firm supports innovative enterprises focused on advancing therapeutic development, diagnostic tools, and other critical health technologies, enabling them to progress from concept to commercialization.
Established in 2010, BioMed Ventures was conceived as the dedicated investment arm of BioMed Realty. This strategic venture leveraged BioMed Realty's significant market presence and specialized expertise within the life science real estate ecosystem. The firm aimed to actively support the growth and development of promising companies, many of which were tenants or partners within BioMed Realty's extensive portfolio of specialized research and development facilities.
Emerging life science companies are the primary beneficiaries of BioMed Ventures' strategic investments, utilizing its capital to propel their research and development efforts. The firm’s overarching vision involves fostering innovation across the broader life science sector. By identifying and nurturing nascent companies, BioMed Ventures contributes to the accelerated development of groundbreaking solutions for pressing global health challenges, shaping the future of medicine and healthcare.
BioMed Ventures has 16 tracked investments across 12 companies. The latest tracked deal is $9.0M Seed in Fauna Bio in September 2021.